SSNA1

SS nuclear autoantigen 1

Basic information

Region (hg38): 9:137188660-137190370

Links

ENSG00000176101NCBI:8636OMIM:610882HGNC:11321Uniprot:O43805AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SSNA1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SSNA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
17
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 17 0 0

Variants in SSNA1

This is a list of pathogenic ClinVar variants found in the SSNA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-137188772-G-T not specified Uncertain significance (Nov 09, 2024)3449787
9-137188776-A-C not specified Uncertain significance (May 24, 2024)3322829
9-137189129-A-G not specified Uncertain significance (Oct 04, 2024)3449785
9-137189131-A-C not specified Uncertain significance (Feb 24, 2025)2295011
9-137189185-A-G not specified Uncertain significance (Jul 26, 2023)2614573
9-137189210-C-T not specified Uncertain significance (Apr 06, 2022)2406065
9-137189233-A-T not specified Uncertain significance (Jun 29, 2022)2298910
9-137189237-T-C not specified Uncertain significance (Dec 05, 2022)2332893
9-137189246-C-T not specified Uncertain significance (Dec 12, 2023)3170421
9-137189251-G-A not specified Uncertain significance (Mar 16, 2022)2204279
9-137189260-C-T not specified Uncertain significance (Jun 21, 2022)2296142
9-137189818-C-G not specified Uncertain significance (Dec 06, 2021)2265275
9-137189826-C-G not specified Uncertain significance (Jun 07, 2024)3322830
9-137189850-A-G not specified Uncertain significance (Mar 12, 2024)3170422
9-137189865-C-G not specified Uncertain significance (Nov 09, 2024)3449786
9-137189871-C-T not specified Uncertain significance (Mar 20, 2023)2515649
9-137189900-G-A not specified Uncertain significance (Jun 27, 2023)2598195

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SSNA1protein_codingprotein_codingENST00000322310 31724
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0003340.38412526701421254090.000566
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.6018167.21.210.00000319769
Missense in Polyphen1214.040.85472193
Synonymous-0.9613730.31.220.00000158226
Loss of Function-0.10454.761.052.01e-758

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.01070.0101
East Asian0.00005460.0000544
Finnish0.000.00
European (Non-Finnish)0.0003490.000318
Middle Eastern0.00005460.0000544
South Asian0.000.00
Other0.0007150.000653

dbNSFP

Source: dbNSFP

Pathway
miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Regulation of PLK1 Activity at G2/M Transition;Recruitment of mitotic centrosome proteins and complexes;Loss of Nlp from mitotic centrosomes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;AURKA Activation by TPX2;G2/M Transition;Mitotic G2-G2/M phases;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic;Anchoring of the basal body to the plasma membrane;Cilium Assembly;Organelle biogenesis and maintenance (Consensus)

Recessive Scores

pRec
0.139

Intolerance Scores

loftool
0.352
rvis_EVS
-0.01
rvis_percentile_EVS
52.85

Haploinsufficiency Scores

pHI
0.217
hipred
Y
hipred_score
0.514
ghis
0.590

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.964

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ssna1
Phenotype

Gene ontology

Biological process
G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;intraciliary transport;ciliary receptor clustering involved in smoothened signaling pathway;ciliary basal body-plasma membrane docking
Cellular component
nucleus;centrosome;cytosol;ciliary basal body
Molecular function
protein binding;identical protein binding